A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: Results of a multicenter placebo-controlled study
Rachel Grossman(Hôpital Saint-Louis), Louis Dubertret, P Amblard, Marion Weber, J Thivolet(Hôpital Edouard Herriot), S Bélaïch, D. L. Lambert(University of Namur), J J Guilhou, P. Combemale(Centre Léon Bérard), J.P. Denoeux, C Martinet, P Souteyrand(Centre Hospitalier Universitaire de Clermont-Ferrand), C. de Bélilovsky, Ph. Lauret, Zvonimir Ostojić, J Bazex(Hôpital Purpan), M. de la Brassinne, Philip Thomas, L. Vaillant(Centre Hospitalier Universitaire de Tours), C Beylot(Université de Bordeaux), A Claudy, Raymond Pamphile
Cited by 139
Related Papers
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
|The Lancet Oncology|2015|432
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas.
|PubMed|2000|267
Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study
|British Journal of Dermatology|2019|197
Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement
|Cytogenetics and Cell Genetics|2008|194
Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study
|Journal of the European Academy of Dermatology and Venereology|2017|192